<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:16 -0700</creation_date>
  <update_date>2013-04-11 15:13:09 -0600</update_date>
  <accession>HMDBP00454</accession>
  <secondary_accessions>
    <accession>5692</accession>
    <accession>HMDBP05612</accession>
  </secondary_accessions>
  <protein_type>Transporter</protein_type>
  <synonyms>
    <synonym>LST-1</synonym>
    <synonym>Liver-specific organic anion transporter 1</synonym>
    <synonym>OATP-2</synonym>
    <synonym>OATP-C</synonym>
    <synonym>Sodium-independent organic anion-transporting polypeptide 2</synonym>
    <synonym>Solute carrier family 21 member 6</synonym>
  </synonyms>
  <gene_name>SLCO1B1</gene_name>
  <general_function>Involved in transporter activity</general_function>
  <specific_function>Mediates the Na(+)-independent transport of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. May play an important role in the clearance of bile acids and organic anions from the liver</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00036</accession>
      <name>Taurocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00054</accession>
      <name>Bilirubin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00307</accession>
      <name>1b-Hydroxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00308</accession>
      <name>3b-Hydroxy-5-cholenoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00311</accession>
      <name>3b,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00312</accession>
      <name>3a,7a,12b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00316</accession>
      <name>2b,3a,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00320</accession>
      <name>3a,4b,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00326</accession>
      <name>1b,3a,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00328</accession>
      <name>12-Ketodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00330</accession>
      <name>3a,4b,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00340</accession>
      <name>3a,7a,12a,19-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00348</accession>
      <name>3b,12a-Dihydroxy-5a-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00359</accession>
      <name>3a,7a-Dihydroxycoprostanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00361</accession>
      <name>3b,7a-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00364</accession>
      <name>3a,6a,7b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00367</accession>
      <name>3a,6b,7b,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00371</accession>
      <name>1,3,12-Trihydroxycholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00376</accession>
      <name>3b,7a,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00377</accession>
      <name>3a,6b,7b,12b-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00381</accession>
      <name>Allolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00384</accession>
      <name>3a,7a-Dihydroxycholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00385</accession>
      <name>12a-Hydroxy-3-oxocholadienic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00390</accession>
      <name>3a,7b,12b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00391</accession>
      <name>7-Ketodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00395</accession>
      <name>3b,7b,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00399</accession>
      <name>3a,6b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00400</accession>
      <name>3,7-Dihydroxy-12-oxocholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00404</accession>
      <name>2b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00411</accession>
      <name>3a,12b-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00414</accession>
      <name>1b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00415</accession>
      <name>3a,6b,7b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00419</accession>
      <name>3b,7a,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00427</accession>
      <name>3b,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00432</accession>
      <name>3a,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00433</accession>
      <name>1,3,7,12-Tetrahydroxycholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00437</accession>
      <name>3a,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00438</accession>
      <name>3b,12a-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00447</accession>
      <name>7a,12a-Dihydroxy-3-oxo-4-cholenoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00460</accession>
      <name>7-Hydroxy-3-oxocholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00467</accession>
      <name>Nutriacholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00476</accession>
      <name>3-Oxo-4,6-choladienoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00478</accession>
      <name>Allodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00502</accession>
      <name>3-Oxocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00503</accession>
      <name>7a-Hydroxy-3-oxo-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00505</accession>
      <name>Allocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00506</accession>
      <name>Alpha-Muricholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00514</accession>
      <name>Allochenodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00518</accession>
      <name>Chenodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00527</accession>
      <name>6a,12a-Dihydroxylithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00545</accession>
      <name>Chenodeoxycholic acid disulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00601</accession>
      <name>Coprocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00619</accession>
      <name>Cholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00626</accession>
      <name>Deoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00659</accession>
      <name>Deoxycholic acid disulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00664</accession>
      <name>Isohyodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00686</accession>
      <name>Isoursodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00713</accession>
      <name>Isoallolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00717</accession>
      <name>Isolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00733</accession>
      <name>Hyodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00760</accession>
      <name>Hyocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00761</accession>
      <name>Lithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00811</accession>
      <name>Murocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00865</accession>
      <name>Muricholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00907</accession>
      <name>Sulfolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00917</accession>
      <name>Ursocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00946</accession>
      <name>Ursodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01181</accession>
      <name>4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02082</accession>
      <name>Bisnorcholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02163</accession>
      <name>Trihydroxycoprostanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02195</accession>
      <name>Varanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02421</accession>
      <name>7-Sulfocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02430</accession>
      <name>(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02431</accession>
      <name>12b-Hydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02451</accession>
      <name>7b,12a-Dihydroxycholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02488</accession>
      <name>7a,12b-dihydroxy-5b-Cholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02492</accession>
      <name>7a-Hydroxy-5b-cholanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02497</accession>
      <name>Glycochenodeoxycholate-3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02504</accession>
      <name>3-Sulfodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02522</accession>
      <name>Chenodeoxycholic acid sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02536</accession>
      <name>Isodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02585</accession>
      <name>3b,12b-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02586</accession>
      <name>Chenodeoxycholic acid 3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02642</accession>
      <name>Ursodeoxycholic acid 3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03873</accession>
      <name>3a,7a,12a-Trihydroxy-5b-cholestanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06898</accession>
      <name>Chenodeoxyglycocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00145</accession>
      <name>Estrone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01425</accession>
      <name>Estrone sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB05022</accession>
      <name>Pravastatin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00248</accession>
      <name>Thyroxine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01220</accession>
      <name>Prostaglandin E2</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00077</accession>
      <name>Dehydroepiandrosterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01917</accession>
      <name>Digoxin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13848</accession>
      <name>4-Hydroxyvalsartan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14365</accession>
      <name>Nelfinavir</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14369</accession>
      <name>Indinavir</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14372</accession>
      <name>Lovastatin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14420</accession>
      <name>Olmesartan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14534</accession>
      <name>Digoxin n</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14646</accession>
      <name>Ritonavir</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14661</accession>
      <name>Caspofungin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14703</accession>
      <name>Methotrexate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00062</accession>
      <name>L-Carnitine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13961</accession>
      <name>O-Desmethylverapamil (D-702)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14900</accession>
      <name>Irinotecan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00151</accession>
      <name>Estradiol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14997</accession>
      <name>Penicillamine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15015</accession>
      <name>Sirolimus</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15044</accession>
      <name>Quinidine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15108</accession>
      <name>Ezetimibe</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15179</accession>
      <name>Rifampin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15186</accession>
      <name>Penicillin G</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15224</accession>
      <name>Ouabain</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15264</accession>
      <name>Pioglitazone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15362</accession>
      <name>Saquinavir</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15371</accession>
      <name>Gemfibrozil</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15465</accession>
      <name>Bezafibrate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15523</accession>
      <name>Liotrix</name>
    </metabolite>
    <metabolite>
      <accession>HMDB30463</accession>
      <name>Hyperforin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01890</accession>
      <name>Acetylcysteine</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>transporter activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>establishment of localization</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>transport</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>cell part</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>membrane</description>
      <go_id/>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Basolateral cell membrane</subcellular_location>
    <subcellular_location>Multi-pass membrane protein</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:1</chromosome_location>
    <locus>12p</locus>
    <gene_sequence>&gt;2076 bp
ATGGACCAAAATCAACATTTGAATAAAACAGCAGAGGCACAACCTTCAGAGAATAAGAAA
ACAAGATACTGCAATGGATTGAAGATGTTCTTGGCAGCTCTGTCACTCAGCTTTATTGCT
AAGACACTAGGTGCAATTATTATGAAAAGTTCCATCATTCATATAGAACGGAGATTTGAG
ATATCCTCTTCTCTTGTTGGTTTTATTGACGGAAGCTTTGAAATTGGAAATTTGCTTGTG
ATTGTATTTGTGAGTTACTTTGGATCCAAACTACATAGACCAAAGTTAATTGGAATCGGT
TGTTTCATTATGGGAATTGGAGGTGTTTTGACTGCTTTGCCACATTTCTTCATGGGATAT
TACAGGTATTCTAAAGAAACTAATATCAATTCATCAGAAAATTCAACATCGACCTTATCC
ACTTGTTTAATTAATCAAATTTTATCACTCAATAGAGCATCACCTGAGATAGTGGGAAAA
GGTTGTTTAAAGGAATCTGGGTCATACATGTGGATATATGTGTTCATGGGTAATATGCTT
CGTGGAATAGGGGAGACTCCCATAGTACCACTGGGGCTTTCTTACATTGATGATTTCGCT
AAAGAAGGACATTCTTCTTTGTATTTAGGTATATTGAATGCAATAGCAATGATTGGTCCA
ATCATTGGCTTTACCCTGGGATCTCTGTTTTCTAAAATGTACGTGGATATTGGATATGTA
GATCTAAGCACTATCAGGATAACTCCTACTGATTCTCGATGGGTTGGAGCTTGGTGGCTT
AATTTCCTTGTGTCTGGACTATTCTCCATTATTTCTTCCATACCATTCTTTTTCTTGCCC
CAAACTCCAAATAAACCACAAAAAGAAAGAAAAGCTTCACTGTCTTTGCATGTGCTGGAA
ACAAATGATGAAAAGGATCAAACAGCTAATTTGACCAATCAAGGAAAAAATATTACCAAA
AATGTGACTGGTTTTTTCCAGTCTTTTAAAAGCATCCTTACTAATCCCCTGTATGTTATG
TTTGTGCTTTTGACGTTGTTACAAGTAAGCAGCTATATTGGTGCTTTTACTTATGTCTTC
AAATACGTAGAGCAACAGTATGGTCAGCCTTCATCTAAGGCTAACATCTTATTGGGAGTC
ATAACCATACCTATTTTTGCAAGTGGAATGTTTTTAGGAGGATATATCATTAAAAAATTC
AAACTGAACACCGTTGGAATTGCCAAATTCTCATGTTTTACTGCTGTGATGTCATTGTCC
TTTTACCTATTATATTTTTTCATACTCTGTGAAAACAAATCAGTTGCCGGACTAACCATG
ACCTATGATGGAAATAATCCAGTGACATCTCATAGAGATGTACCACTTTCTTATTGCAAC
TCAGACTGCAATTGTGATGAAAGTCAATGGGAACCAGTCTGTGGAAACAATGGAATAACT
TACATCTCACCCTGTCTAGCAGGTTGCAAATCTTCAAGTGGCAATAAAAAGCCTATAGTG
TTTTACAACTGCAGTTGTTTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCCCAT
TTGGGTGAATGCCCAAGAGATGATGCTTGTACAAGGAAATTTTACTTTTTTGTTGCAATA
CAAGTCTTGAATTTATTTTTCTCTGCACTTGGAGGCACCTCACATGTCATGCTGATTGTT
AAAATTGTTCAACCTGAATTGAAATCACTTGCACTGGGTTTCCACTCAATGGTTATACGA
GCACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATACAACGTGTATA
AAGTGGTCCACCAACAACTGTGGCACACGTGGGTCATGTAGGACATATAATTCCACATCA
TTTTCAAGGGTCTACTTGGGCTTGTCTTCAATGTTAAGAGTCTCATCACTTGTTTTATAT
ATTATATTAATTTATGCCATGAAGAAAAAATATCAAGAGAAAGATATCAATGCATCAGAA
AATGGAAGTGTCATGGATGAAGCAAACTTAGAATCCTTAAATAAAAATAAACATTTTGTC
CCTTCTGCTGGGGCAGATAGTGAAACACATTGTTAA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>691</residue_number>
    <molecular_weight>76448.0</molecular_weight>
    <theoretical_pi>8.68</theoretical_pi>
    <pfams>
      <pfam>
        <name>Kazal_2</name>
        <pfam_id>PF07648</pfam_id>
      </pfam>
      <pfam>
        <name>OATP</name>
        <pfam_id>PF03137</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
      <region>97-117</region>
      <region>207-227</region>
      <region>259-279</region>
      <region>336-356</region>
      <region>376-396</region>
      <region>410-430</region>
      <region>575-595</region>
    </transmembrane_regions>
    <signal_regions>
      <region>None</region>
    </signal_regions>
    <protein_sequence>&gt;Solute carrier organic anion transporter family member 1B1
MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKSSIIHIERRFE
ISSSLVGFIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCFIMGIGGVLTALPHFFMGY
YRYSKETNINSSENSTSTLSTCLINQILSLNRASPEIVGKGCLKESGSYMWIYVFMGNML
RGIGETPIVPLGLSYIDDFAKEGHSSLYLGILNAIAMIGPIIGFTLGSLFSKMYVDIGYV
DLSTIRITPTDSRWVGAWWLNFLVSGLFSIISSIPFFFLPQTPNKPQKERKASLSLHVLE
TNDEKDQTANLTNQGKNITKNVTGFFQSFKSILTNPLYVMFVLLTLLQVSSYIGAFTYVF
KYVEQQYGQPSSKANILLGVITIPIFASGMFLGGYIIKKFKLNTVGIAKFSCFTAVMSLS
FYLLYFFILCENKSVAGLTMTYDGNNPVTSHRDVPLSYCNSDCNCDESQWEPVCGNNGIT
YISPCLAGCKSSSGNKKPIVFYNCSCLEVTGLQNRNYSAHLGECPRDDACTRKFYFFVAI
QVLNLFFSALGGTSHVMLIVKIVQPELKSLALGFHSMVIRALGGILAPIYFGALIDTTCI
KWSTNNCGTRGSCRTYNSTSFSRVYLGLSSMLRVSSLVLYIILIYAMKKKYQEKDINASE
NGSVMDEANLESLNKNKHFVPSAGADSETHC</protein_sequence>
  </protein_properties>
  <genbank_protein_id>5006265</genbank_protein_id>
  <uniprot_id>Q9Y6L6</uniprot_id>
  <uniprot_name>SO1B1_HUMAN</uniprot_name>
  <pdb_ids>
  </pdb_ids>
  <genbank_gene_id>AB026257</genbank_gene_id>
  <genecard_id>SLCO1B1</genecard_id>
  <geneatlas_id>SLCO1B1</geneatlas_id>
  <hgnc_id>HGNC:10959</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63.</reference_text>
      <pubmed_id>10358072</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8.</reference_text>
      <pubmed_id>10601278</pubmed_id>
    </reference>
    <reference>
      <reference_text>Konig J, Cui Y, Nies AT, Keppler D: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64.</reference_text>
      <pubmed_id>10644574</pubmed_id>
    </reference>
    <reference>
      <reference_text>Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8.</reference_text>
      <pubmed_id>10779507</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tirona RG, Leake BF, Merino G, Kim RB: Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem. 2001 Sep 21;276(38):35669-75. Epub 2001 Jul 26.</reference_text>
      <pubmed_id>11477075</pubmed_id>
    </reference>
    <reference>
      <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
      <pubmed_id>12196548</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T: Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002 Aug;302(2):804-13.</reference_text>
      <pubmed_id>12130747</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Hartmann G, Cheung AK, Piquette-Miller M: Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther. 2002 Oct;303(1):273-81.</reference_text>
        <pubmed_id>12235261</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A: Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin. J Pharm Pharmacol. 2003 Jul;55(7):1013-20.</reference_text>
        <pubmed_id>12906759</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8.</reference_text>
        <pubmed_id>10601278</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63.</reference_text>
        <pubmed_id>10358072</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Bilirubin</name>
        <accession>HMDB00054</accession>
      </metabolite>
      <reference>
        <reference_text>Zhang W, He YJ, Gan Z, Fan L, Li Q, Wang A, Liu ZQ, Deng S, Huang YF, Xu LY, Zhou HH: OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation. Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1240-4.</reference_text>
        <pubmed_id>17973861</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1b-Hydroxycholic acid</name>
        <accession>HMDB00307</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b-Hydroxy-5-cholenoic acid</name>
        <accession>HMDB00308</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00311</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7a,12b-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00312</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>2b,3a,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00316</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,4b,7a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00320</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1b,3a,12a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00326</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>12-Ketodeoxycholic acid</name>
        <accession>HMDB00328</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,4b,12a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00330</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7a,12a,19-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00340</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,12a-Dihydroxy-5a-cholanoic acid</name>
        <accession>HMDB00348</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7a-Dihydroxycoprostanic acid</name>
        <accession>HMDB00359</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,7a-Dihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00361</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,6a,7b-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00364</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,6b,7b,12a-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00367</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1,3,12-Trihydroxycholan-24-oic acid</name>
        <accession>HMDB00371</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,7a,12a-Trihydroxy-5a-Cholanoic acid</name>
        <accession>HMDB00376</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,6b,7b,12b-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00377</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Allolithocholic acid</name>
        <accession>HMDB00381</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7a-Dihydroxycholanoic acid</name>
        <accession>HMDB00384</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>12a-Hydroxy-3-oxocholadienic acid</name>
        <accession>HMDB00385</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7b,12b-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00390</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7-Ketodeoxycholic acid</name>
        <accession>HMDB00391</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,7b,12a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00395</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,6b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00399</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3,7-Dihydroxy-12-oxocholanoic acid</name>
        <accession>HMDB00400</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>2b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00404</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,12b-Dihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00411</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00414</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,6b,7b-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00415</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,7a,12a-Trihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00419</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
        <accession>HMDB00427</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
        <accession>HMDB00432</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>1,3,7,12-Tetrahydroxycholan-24-oic acid</name>
        <accession>HMDB00433</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
        <accession>HMDB00437</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,12a-Dihydroxy-5b-cholanoic acid</name>
        <accession>HMDB00438</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7a,12a-Dihydroxy-3-oxo-4-cholenoic acid</name>
        <accession>HMDB00447</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7-Hydroxy-3-oxocholanoic acid</name>
        <accession>HMDB00460</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Nutriacholic acid</name>
        <accession>HMDB00467</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3-Oxo-4,6-choladienoic acid</name>
        <accession>HMDB00476</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Allodeoxycholic acid</name>
        <accession>HMDB00478</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3-Oxocholic acid</name>
        <accession>HMDB00502</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7a-Hydroxy-3-oxo-5b-cholanoic acid</name>
        <accession>HMDB00503</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Allocholic acid</name>
        <accession>HMDB00505</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Alpha-Muricholic acid</name>
        <accession>HMDB00506</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Allochenodeoxycholic acid</name>
        <accession>HMDB00514</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Chenodeoxycholic acid</name>
        <accession>HMDB00518</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>6a,12a-Dihydroxylithocholic acid</name>
        <accession>HMDB00527</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Chenodeoxycholic acid disulfate</name>
        <accession>HMDB00545</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Coprocholic acid</name>
        <accession>HMDB00601</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Cholic acid</name>
        <accession>HMDB00619</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Cholic acid</name>
        <accession>HMDB00619</accession>
      </metabolite>
      <reference>
        <reference_text>Hartmann G, Cheung AK, Piquette-Miller M: Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther. 2002 Oct;303(1):273-81.</reference_text>
        <pubmed_id>12235261</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Cholic acid</name>
        <accession>HMDB00619</accession>
      </metabolite>
      <reference>
        <reference_text>Konig J, Cui Y, Nies AT, Keppler D: A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol. 2000 Jan;278(1):G156-64.</reference_text>
        <pubmed_id>10644574</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Cholic acid</name>
        <accession>HMDB00619</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Deoxycholic acid</name>
        <accession>HMDB00626</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Deoxycholic acid disulfate</name>
        <accession>HMDB00659</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isohyodeoxycholic acid</name>
        <accession>HMDB00664</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isoursodeoxycholic acid</name>
        <accession>HMDB00686</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isoallolithocholic acid</name>
        <accession>HMDB00713</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isolithocholic acid</name>
        <accession>HMDB00717</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Hyodeoxycholic acid</name>
        <accession>HMDB00733</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Hyocholic acid</name>
        <accession>HMDB00760</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Lithocholic acid</name>
        <accession>HMDB00761</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Murocholic acid</name>
        <accession>HMDB00811</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Muricholic acid</name>
        <accession>HMDB00865</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sulfolithocholic acid</name>
        <accession>HMDB00907</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ursocholic acid</name>
        <accession>HMDB00917</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ursodeoxycholic acid</name>
        <accession>HMDB00946</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol</name>
        <accession>HMDB01181</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Bisnorcholic acid</name>
        <accession>HMDB02082</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Trihydroxycoprostanoic acid</name>
        <accession>HMDB02163</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Varanic acid</name>
        <accession>HMDB02195</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7-Sulfocholic acid</name>
        <accession>HMDB02421</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid</name>
        <accession>HMDB02430</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>12b-Hydroxy-5b-cholanoic acid</name>
        <accession>HMDB02431</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7b,12a-Dihydroxycholanoic acid</name>
        <accession>HMDB02451</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7a,12b-dihydroxy-5b-Cholan-24-oic acid</name>
        <accession>HMDB02488</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>7a-Hydroxy-5b-cholanic acid</name>
        <accession>HMDB02492</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Glycochenodeoxycholate-3-sulfate</name>
        <accession>HMDB02497</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3-Sulfodeoxycholic acid</name>
        <accession>HMDB02504</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Chenodeoxycholic acid sulfate</name>
        <accession>HMDB02522</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isodeoxycholic acid</name>
        <accession>HMDB02536</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3b,12b-Dihydroxy-5b-cholanoic acid</name>
        <accession>HMDB02585</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Chenodeoxycholic acid 3-sulfate</name>
        <accession>HMDB02586</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ursodeoxycholic acid 3-sulfate</name>
        <accession>HMDB02642</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>3a,7a,12a-Trihydroxy-5b-cholestanoic acid</name>
        <accession>HMDB03873</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Chenodeoxyglycocholic acid</name>
        <accession>HMDB06898</accession>
      </metabolite>
      <reference>
        <reference_text>Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J: A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002 Nov 8;277(45):43058-63. Epub 2002 Aug 23.</reference_text>
        <pubmed_id>12196548</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4-Hydroxyvalsartan</name>
        <accession>HMDB13848</accession>
      </metabolite>
      <reference>
        <reference_text>Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611. Epub 2009 Nov 20.</reference_text>
        <pubmed_id>19936896</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4-Hydroxyvalsartan</name>
        <accession>HMDB13848</accession>
      </metabolite>
      <reference>
        <reference_text>Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data. Chem Biodivers. 2009 Nov;6(11):1975-87.</reference_text>
        <pubmed_id>19937834</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Nelfinavir</name>
        <accession>HMDB14365</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Indinavir</name>
        <accession>HMDB14369</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Lovastatin</name>
        <accession>HMDB14372</accession>
      </metabolite>
      <reference>
        <reference_text>Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, Kirchgessner TG: A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8.</reference_text>
        <pubmed_id>10601278</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Lovastatin</name>
        <accession>HMDB14372</accession>
      </metabolite>
      <reference>
        <reference_text>Sandhu P, Lee W, Xu X, Leake BF, Yamazaki M, Stone JA, Lin JH, Pearson PG, Kim RB: Hepatic uptake of the novel antifungal agent caspofungin.  Drug Metab Dispos. 2005 May;33(5):676-82. Epub 2005 Feb 16.</reference_text>
        <pubmed_id>15716364</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Olmesartan</name>
        <accession>HMDB14420</accession>
      </metabolite>
      <reference>
        <reference_text>Nakagomi-Hagihara R, Nakai D, Kawai K, Yoshigae Y, Tokui T, Abe T, Ikeda T: OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Drug Metab Dispos. 2006 May;34(5):862-9. Epub 2006 Feb 24.</reference_text>
        <pubmed_id>16501004</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>van Montfoort JE, Schmid TE, Adler ID, Meier PJ, Hagenbuch B: Functional characterization of the mouse organic-anion-transporting polypeptide 2. Biochim Biophys Acta. 2002 Aug 19;1564(1):183-8.</reference_text>
        <pubmed_id>12101011</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Dagenais C, Ducharme J, Pollack GM: Uptake and efflux of the peptidic delta-opioid receptor agonist.  Neurosci Lett. 2001 Apr 6;301(3):155-8.</reference_text>
        <pubmed_id>11257421</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Sugiyama D, Kusuhara H, Shitara Y, Abe T, Meier PJ, Sekine T, Endou H, Suzuki H, Sugiyama Y: Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier. J Pharmacol Exp Ther. 2001 Jul;298(1):316-22.</reference_text>
        <pubmed_id>11408557</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Hagenbuch N, Reichel C, Stieger B, Cattori V, Fattinger KE, Landmann L, Meier PJ, Kullak-Ublick GA: Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol. 2001 Jun;34(6):881-7.</reference_text>
        <pubmed_id>11451172</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Gao B, Wenzel A, Grimm C, Vavricka SR, Benke D, Meier PJ, Reme CE: Localization of organic anion transport protein 2 in the apical region of rat retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):510-4.</reference_text>
        <pubmed_id>11818398</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, Sugiyama Y: Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res. 2002 Feb;19(2):147-53.</reference_text>
        <pubmed_id>11883641</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ritonavir</name>
        <accession>HMDB14646</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Caspofungin</name>
        <accession>HMDB14661</accession>
      </metabolite>
      <reference>
        <reference_text>Sandhu P, Lee W, Xu X, Leake BF, Yamazaki M, Stone JA, Lin JH, Pearson PG, Kim RB: Hepatic uptake of the novel antifungal agent caspofungin.  Drug Metab Dispos. 2005 May;33(5):676-82. Epub 2005 Feb 16.</reference_text>
        <pubmed_id>15716364</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Methotrexate</name>
        <accession>HMDB14703</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.</reference_text>
        <pubmed_id>11375950</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Methotrexate</name>
        <accession>HMDB14703</accession>
      </metabolite>
      <reference>
        <reference_text>van de Steeg E, van der Kruijssen CM, Wagenaar E, Burggraaff JE, Mesman E, Kenworthy KE, Schinkel AH: Methotrexate pharmacokinetics in transgenic mice with liver-specific expression of human organic anion-transporting polypeptide 1B1 (SLCO1B1). Drug Metab Dispos. 2009 Feb;37(2):277-81. Epub 2008 Nov 20.</reference_text>
        <pubmed_id>19022939</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>L-Carnitine</name>
        <accession>HMDB00062</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A: Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin. J Pharm Pharmacol. 2003 Jul;55(7):1013-20.</reference_text>
        <pubmed_id>12906759</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>O-Desmethylverapamil (D-702)</name>
        <accession>HMDB13961</accession>
      </metabolite>
      <reference>
        <reference_text>Oostendorp RL, van de Steeg E, van der Kruijssen CM, Beijnen JH, Kenworthy KE, Schinkel AH, Schellens JH: Organic anion-transporting polypeptide 1B1 mediates transport of Gimatecan and BNP1350 and can be inhibited by several classic ATP-binding cassette (ABC) B1 and/or ABCG2 inhibitors. Drug Metab Dispos. 2009 Apr;37(4):917-23. Epub 2009 Jan 12.</reference_text>
        <pubmed_id>19139163</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Irinotecan</name>
        <accession>HMDB14900</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Minami H, Sugiura S, Tsuji A, Tamai I: Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab Dispos. 2005 Mar;33(3):434-9. Epub 2004 Dec 17.</reference_text>
        <pubmed_id>15608127</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Estradiol</name>
        <accession>HMDB00151</accession>
      </metabolite>
      <reference>
        <reference_text>Tamai I, Nozawa T, Koshida M, Nezu J, Sai Y, Tsuji A: Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C. Pharm Res. 2001 Sep;18(9):1262-9.</reference_text>
        <pubmed_id>11683238</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Penicillamine</name>
        <accession>HMDB14997</accession>
      </metabolite>
      <reference>
        <reference_text>Gui C, Hagenbuch B: Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Sci. 2009 Nov;18(11):2298-306.</reference_text>
        <pubmed_id>19760661</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Sirolimus</name>
        <accession>HMDB15015</accession>
      </metabolite>
      <reference>
        <reference_text>Fehrenbach T, Cui Y, Faulstich H, Keppler D: Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins. Naunyn Schmiedebergs Arch Pharmacol. 2003 Nov;368(5):415-20. Epub 2003 Oct       3.</reference_text>
        <pubmed_id>14530907</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Quinidine</name>
        <accession>HMDB15044</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A: Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin. J Pharm Pharmacol. 2003 Jul;55(7):1013-20.</reference_text>
        <pubmed_id>12906759</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ezetimibe</name>
        <accession>HMDB15108</accession>
      </metabolite>
      <reference>
        <reference_text>Oswald S, Nassif A, Modess C, Keiser M, Ulrich A, Runge D, Hanke U, Lutjohann D, Engel A, Weitschies W, Siegmund W: Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clin Pharmacol Ther. 2011 Apr;89(4):524-8. Epub 2011 Mar 2.</reference_text>
        <pubmed_id>21368751</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K: Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002 Jul;36(1):164-72.</reference_text>
        <pubmed_id>12085361</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Sharma P, Holmes VE, Elsby R, Lambert C, Surry D: Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Xenobiotica. 2010 Jan;40(1):24-37.</reference_text>
        <pubmed_id>19919292</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Penicillin G</name>
        <accession>HMDB15186</accession>
      </metabolite>
      <reference>
        <reference_text>Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, Tsuji A: Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000 Jun 24;273(1):251-60.</reference_text>
        <pubmed_id>10873595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ouabain</name>
        <accession>HMDB15224</accession>
      </metabolite>
      <reference>
        <reference_text>van Montfoort JE, Schmid TE, Adler ID, Meier PJ, Hagenbuch B: Functional characterization of the mouse organic-anion-transporting polypeptide 2. Biochim Biophys Acta. 2002 Aug 19;1564(1):183-8.</reference_text>
        <pubmed_id>12101011</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pioglitazone</name>
        <accession>HMDB15264</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Sugiura S, Nakajima M, Goto A, Yokoi T, Nezu J, Tsuji A, Tamai I: Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos. 2004 Mar;32(3):291-4.</reference_text>
        <pubmed_id>14977862</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Saquinavir</name>
        <accession>HMDB15362</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Gemfibrozil</name>
        <accession>HMDB15371</accession>
      </metabolite>
      <reference>
        <reference_text>Sharma P, Holmes VE, Elsby R, Lambert C, Surry D: Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Xenobiotica. 2010 Jan;40(1):24-37.</reference_text>
        <pubmed_id>19919292</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Bezafibrate</name>
        <accession>HMDB15465</accession>
      </metabolite>
      <reference>
        <reference_text>Sharma P, Holmes VE, Elsby R, Lambert C, Surry D: Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions. Xenobiotica. 2010 Jan;40(1):24-37.</reference_text>
        <pubmed_id>19919292</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Liotrix</name>
        <accession>HMDB15523</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63.</reference_text>
        <pubmed_id>10358072</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Hyperforin</name>
        <accession>HMDB30463</accession>
      </metabolite>
      <reference>
        <reference_text>Tirona RG, Leake BF, Wolkoff AW, Kim RB: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther. 2003 Jan;304(1):223-8.</reference_text>
        <pubmed_id>12490595</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Acetylcysteine</name>
        <accession>HMDB01890</accession>
      </metabolite>
      <reference>
        <reference_text>Daily A, Monks NR, Leggas M, Moscow JA: Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition. Toxicon. 2010 Apr 1;55(4):827-37. Epub 2009 Nov 24.</reference_text>
        <pubmed_id>19944114</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
